216 related articles for article (PubMed ID: 25455505)
41. Pituitary metastases from follicular thyroid carcinoma.
Prodam F; Pagano L; Belcastro S; Golisano G; Busti A; Samà M; Caputo M; Bellone S; Voci A; Valente G; Aimaretti G
Thyroid; 2010 Jul; 20(7):823-30. PubMed ID: 20604687
[TBL] [Abstract][Full Text] [Related]
42. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
[TBL] [Abstract][Full Text] [Related]
43. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
44. [Distant metastases as the initial manifestation of follicular thyroid carcinoma].
Ríos A; Manuel Rodríguez J; Balsalobre MD; Febrero B; Tébar J; Parrilla P
Endocrinol Nutr; 2009 Apr; 56(4):213-4. PubMed ID: 19627740
[No Abstract] [Full Text] [Related]
45. Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
Muratet JP; Giraud P; Daver A; Minier JF; Gamelin E; Larra F
J Nucl Med; 1997 Sep; 38(9):1362-8. PubMed ID: 9293788
[TBL] [Abstract][Full Text] [Related]
46. An upper cervical cord compression secondary to occult follicular thyroid carcinoma metastases successfully treated with multiple radioiodine therapies: A clinical case report.
Dong P; Chen N; Li L; Huang R
Medicine (Baltimore); 2017 Oct; 96(41):e8215. PubMed ID: 29019888
[TBL] [Abstract][Full Text] [Related]
47. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
48. Solitary skull metastasis from occult thyroid carcinoma.
Inci S; Akbay A; Bertan V; Gedikoğlu G; Onol B
J Neurosurg Sci; 1994 Mar; 38(1):63-6. PubMed ID: 7965145
[TBL] [Abstract][Full Text] [Related]
49. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A
J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
[TBL] [Abstract][Full Text] [Related]
50. Follicular thyroid carcinoma with skull metastases.
Chiofalo MG; Setola SV; Di Gennaro F; Fulciniti F; Catapano G; Losito NS; Sandomenico F; Catalano O; Pezzullo L
Endocr J; 2015; 62(4):363-9. PubMed ID: 25797278
[TBL] [Abstract][Full Text] [Related]
51. Thymic uptake after high-dose I-131 treatment in patients with differentiated thyroid carcinoma: a brief review of possible causes and management.
Arce MB; Molina TC; Hernández TM; de la Cinta Calvo Morón M; Herrero CH; De La Riva Pérez PA; Montaño JC
Endocrinol Nutr; 2015 Jan; 62(1):19-23. PubMed ID: 25160708
[TBL] [Abstract][Full Text] [Related]
52. Use of
Oliván-Sasot P; Falgás-Lacueva M; García-Sánchez J; Vera-Pinto V; Olivas-Arroyo C; Bello-Arques P
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):116-119. PubMed ID: 27793633
[TBL] [Abstract][Full Text] [Related]
53. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
Blum M; Tiu S; Chu M; Goel S; Friedman K
Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
[TBL] [Abstract][Full Text] [Related]
54. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
56. The Role of Radiotherapy in Skull Metastasis of Thyroid Follicular Carcinoma.
Cihan BY; Koc A; Tokmak TT
Klin Onkol; 2019; 32(4):300-302. PubMed ID: 31426647
[TBL] [Abstract][Full Text] [Related]
57. Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan.
Ceccarelli C; Bianchi F; Trippi D; Brozzi F; Di Martino F; Santini P; Elisei R; Pinchera A
J Endocrinol Invest; 2004 Oct; 27(9):866-9. PubMed ID: 15648552
[TBL] [Abstract][Full Text] [Related]
58. Stunning effects after a diagnostic dose of iodine-131.
Kao CH; Yen TC
Nuklearmedizin; 1998 Jan; 37(1):30-2. PubMed ID: 9467167
[TBL] [Abstract][Full Text] [Related]
59. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
60. Occult carcinoma of the thyroid presenting with orbital metastasis.
Mansberg R; Son H; Kean AM
Clin Nucl Med; 2006 Feb; 31(2):109-11. PubMed ID: 16424702
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
